Zachary Mouri

Learn More
The combination of cisplatin and 5-fluorouracil (5-FU) is considered to be the standard treatment in induction chemotherapy for patients with squamous cell carcinoma of the head and neck. Capecitabine (Xeloda) is an oral fluoropyrimidine that is preferentially activated at the tumoral level, exploiting the higher thymidine phosphorylase activity in tumoral(More)
This paper presents the design and the implementation of a compiler and runtime infrastructure for automatic program distribution. We are building a research infrastructure that enables experimentation with various program partitioning and mapping strategies and the study of automatic distribution's effect on resource consumption (e.g., CPU, memory,(More)
Capecitabine is a highly active oral fluoropyrimidine that is an attractive alternative to 5-fluorouracil in colorectal cancer treatment. The current study, undertaken in 27 patients with gastrointestinal tumours, aimed to assess the toxicity and potential for significant pharmacokinetic interactions of a combination regimen incorporating capecitabine with(More)
  • 1